Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,396	8,799	9,485	7,960	11,811	9,176
Market Cap Growth	33.48%	-7.24%	19.16%	-32.61%	28.71%	15.82%
Enterprise Value	10,856	7,548	8,212	6,852	10,829	8,338
Last Close Price	27.19	19.30	20.27	17.01	25.24	19.61
PE Ratio	162.99	87.68	89.10	70.45	76.04	-
Forward PE	-	48.99	48.99	48.99	48.99	48.99
PS Ratio	8.42	5.55	5.97	5.12	7.69	6.96
PB Ratio	3.30	2.40	2.50	2.18	3.34	2.62
P/TBV Ratio	4.25	3.15	3.29	2.90	4.50	3.63
P/FCF Ratio	44.36	40.39	45.08	48.92	61.13	60.12
P/OCF Ratio	37.48	30.85	31.72	30.39	36.80	37.55
EV/Sales Ratio	7.37	4.76	5.17	4.41	7.05	6.32
EV/EBITDA Ratio	50.82	28.43	29.15	27.01	47.63	42.36
EV/EBIT Ratio	97.64	46.25	59.45	47.94	87.02	89.17
EV/FCF Ratio	38.84	34.64	39.03	42.12	56.04	54.63
Debt / Equity Ratio	0.02	0.03	0.03	0.04	0.02	0.02
Debt / EBITDA Ratio	0.32	0.42	0.45	0.50	0.33	0.30
Debt / FCF Ratio	0.26	0.57	0.61	0.87	0.43	0.38
Asset Turnover	0.28	0.30	0.30	0.30	0.31	0.27
Inventory Turnover	1.87	2.07	2.04	2.15	2.11	2.04
Quick Ratio	1.58	1.47	1.49	1.36	1.24	1.23
Current Ratio	1.77	1.65	1.69	1.57	1.46	1.47
Return on Equity (ROE)	1.52%	2.40%	2.65%	2.97%	4.30%	-3.65%
Return on Assets (ROA)	1.48%	1.91%	1.61%	1.73%	1.57%	1.20%
Return on Invested Capital (ROIC)	3.31%	4.66%	4.33%	4.08%	3.43%	3.69%
Return on Capital Employed (ROCE)	3.30%	4.30%	3.50%	3.70%	3.40%	2.60%
Earnings Yield	0.60%	1.14%	1.12%	1.42%	1.31%	-1.38%
FCF Yield	2.25%	2.48%	2.22%	2.04%	1.64%	1.66%
Payout Ratio	-	-	-	-	1.03%	-
Buyback Yield / Dilution	1.13%	1.45%	1.69%	-0.02%	-0.17%	-4.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.